You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune effector Cell associated Neurotoxicity Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Effector Cell-Associated Neurotoxicity Syndrome

Not yet recruiting
  • Immune Effector Cell Associated Neurotoxicity Syndrome
    • (no location specified)
    Dec 1, 2022

    Lymphoma, B-Cell, Neurotoxicity Trial in Montpellier (Magnetic Resonance Imaging with contrast injection, Blood withdrawal,

    Not yet recruiting
    • Lymphoma, B-Cell
    • Neurotoxicity
    • Magnetic Resonance Imaging with contrast injection
    • +2 more
    • Montpellier, Occitanie, France
      Neurology department, Montpellier University Hospital
    Aug 19, 2022

    EEG Encephalopathy Patterns in Immune Effectors Cells-associated

    Completed
    • Immune Effector Cell Encephalopathy
    • Neurotoxicity
      • Montpellier, France
        Uhmontpellier
      Apr 11, 2022

      Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin Trial in Birmingham (Siltuximab)

      Recruiting
      • Cytokine Release Syndrome
      • +4 more
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Nov 17, 2021

      Cytokine Release Syndrome Trial in United States (Itacitinib, Immune effector cell therapy, Placebo)

      Recruiting
      • Cytokine Release Syndrome
      • Miami, Florida
      • +9 more
      Oct 25, 2022

      Using IMC to Analyze the Impact of ICANS on Microglia

      Recruiting
      • ICANS, Grade Unspecified
      • CAR T-Cell-Related Encephalopathy Syndrome
      • There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
      • Freiburg, Baden Württemberg, Germany
        Freiburg University Medical Center
      Apr 12, 2023

      Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)

      Recruiting
      • Non-Hodgkin Lymphoma
      • Biospecimen Collection
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jan 13, 2023

      Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

      Not yet recruiting
      • Recurrent B Acute Lymphoblastic Leukemia
      • +5 more
      • Interferon Beta-1A
      • +10 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 6, 2023

      Systemic Inflammatory Response Syndrome Trial in Madrid (Allogeneic thyTreg 5.000.000, Allogeneic thyTreg 10.000.000)

      Recruiting
      • Systemic Inflammatory Response Syndrome
      • Allogeneic thyTreg 5.000.000
      • Allogeneic thyTreg 10.000.000
      • Madrid, Spain
        Hospital General Universitario Gregorio Marañon
      Sep 22, 2023

      B-Cell Non-Hodgkin Lymphoma Trial in Seattle (Anakinra)

      Recruiting
      • B-Cell Non-Hodgkin Lymphoma
      • Anakinra
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

      Recruiting
      • B-Cell Lymphoblastic Leukemia
      • Acute Lymphoblastic Leukemia
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 28, 2023

      Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)

      Recruiting
      • Lymphoma
      • +4 more
      • iC9-CAR19 T cells
      • +4 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Dec 2, 2022

      Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

      Not yet recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center
      Oct 13, 2023

      Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

      Not yet recruiting
      • Head and Neck Cancer
      • +3 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Oct 18, 2023

      Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

      Not yet recruiting
      • Light Chain (AL) Amyloidosis
      • NXC-201 CAR-T
      • Sacramento, California
        University of California Davis Medical Center
      Oct 19, 2023

      T-cell Acute Lymphoblastic Leukemia, Lymphoblastic T-Cell Lymphoma Trial in Barcelona (CD1a-CAR T)

      Not yet recruiting
      • T-cell Acute Lymphoblastic Leukemia
      • Lymphoblastic T-Cell Lymphoma
      • CD1a-CAR T
      • Barcelona, Spain
      • +1 more
      Jan 10, 2023

      Diffuse Large B Cell Lymphoma Trial (Bridging Radiotherapy)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • Bridging Radiotherapy
      • Leeds, United Kingdom
      • +2 more
      Dec 6, 2022

      Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

      Not yet recruiting
      • Non-Hodgkin Lymphoma
      • Large B-cell Lymphoma
      • Axicabtagene Ciloleucel
      • Palo Alto, California
        Stanford University
      Mar 20, 2023

      Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

      Not yet recruiting
      • Blastoid Variant Mantle Cell Lymphoma
      • +2 more
      • Biopsy
      • +8 more
      • Duarte, California
        City of Hope Medical Center
      May 15, 2023

      Multiple Myeloma Trial in Houston (Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A))

      Not yet recruiting
      • Multiple Myeloma
      • Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A)
      • Houston, Texas
        The University of Texas MD Anderson Cancer Center
      Jan 13, 2023

      B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

      Recruiting
      • B-Cell Lymphoma
      • +8 more
      • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
      • Pittsburgh, Pennsylvania
        AHN Cancer Institute - West Penn Hospital
      Aug 10, 2022

      B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Duarte (Best Practice, Cognitive Intervention, Comprehensive Geriatric

      Recruiting
      • B-Cell Non-Hodgkin Lymphoma
      • Multiple Myeloma
      • Best Practice
      • +5 more
      • Duarte, California
        City of Hope Medical Center
      Sep 19, 2023

      Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • iC9-CAR19 cells
      • +3 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Dec 21, 2022

      Epithelial Tumors, Malignant Trial in Randwick (MT-302 (A))

      Recruiting
      • Epithelial Tumors, Malignant
      • MT-302 (A)
      • Randwick, New South Wales, Australia
        Scientia Clinical Research Ltd
      Aug 1, 2023

      T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

      Withdrawn
      • T-cell Acute Lymphoblastic Leukemia
      • T-lymphoblastic Lymphoma
      • Target CD7 CAR-T cells
      • Kunming, Yunnan, China
        920th Hospital of Joint Logistics Support Force of People's Libe
      Nov 23, 2022